Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Iovance Biotherapeutics Inc’s current trading price is -35.30% away from its 52-week high, while its distance from the 52-week low is 269.47%. The stock’s price range during this period has varied between $3.21 and $18.33. The company, active in the Healthcare sector, saw a trading volume of around 3.88 million for the day, considerably lower average daily volume of 9.05 million observed over the last three months.
Iovance Biotherapeutics Inc had a pretty favorable run when it comes to the market performance. Over the past year, the company’s stock reached a high of $18.33 on 02/28/24, while the lowest price during the same period was $3.21 on 10/19/23.
How Financial Performance Impacts Market Capitalization
Iovance Biotherapeutics Inc (IOVA) has experienced a quarterly rise of 52.44% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 3.31B and boasts a workforce of 557 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 10.83, with a change in price of +6.29. Similarly, Iovance Biotherapeutics Inc recorded 8,787,488 in trading volume during the last 100 days, posting a change of +112.93%.
How IOVA’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for IOVA stands at 0.13. Similarly, the long-term debt-to-equity ratio is also 0.12.
IOVA Stock Stochastic Average
As of today, the raw stochastic average of Iovance Biotherapeutics Inc over the last 50 days is at 31.53%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 20.38%. Further, the company’s Stochastic %K and %D values for the last 20 days were 11.32% and 7.97%, respectively.
IOVA Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. This year’s metric has recorded a Price increase of 45.88%. However, over the past six months, we’ve seen a weaker performance of 256.16%. The price of IOVA leaped by -21.04% over the last 30 days. And in the last five days, it has fallen by -0.50%.
